Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (793)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,160
Price
$502.44
Total Value
$1.09M
Shares Held After
327,283
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
708
Price
$501.52
Total Value
$355.08K
Shares Held After
329,443
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
492
Price
$500.19
Total Value
$246.10K
Shares Held After
330,151
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,220
Price
$499.15
Total Value
$608.97K
Shares Held After
330,643
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,080
Price
$498.45
Total Value
$1.04M
Shares Held After
331,863
% of Holdings
0.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
4,000
Price
$108.99
Total Value
$435.96K
Shares Held After
58,839
% of Holdings
6.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
8,896
Price
$108.04
Total Value
$961.12K
Shares Held After
62,839
% of Holdings
12.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
3,000
Price
$106.83
Total Value
$320.48K
Shares Held After
71,735
% of Holdings
4.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
3,100
Price
$106.13
Total Value
$329.01K
Shares Held After
74,735
% of Holdings
4.0%
TENAX THERAPEUTICS, INC. (TENX)
Doogan Declan — Director
Shares
53,000
Price
$1.92
Total Value
$101.76K
Shares Held After
55,274
% of Holdings
95.9%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
96,125
Price
$63.64
Total Value
$6.12M
Shares Held After
432,886
% of Holdings
18.2%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
99,716
Price
$63.26
Total Value
$6.31M
Shares Held After
529,011
% of Holdings
15.9%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
47,746
Price
$63.61
Total Value
$3.04M
Shares Held After
98,197
% of Holdings
32.7%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
65,104
Price
$63.12
Total Value
$4.11M
Shares Held After
145,943
% of Holdings
30.8%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
79,113
Price
$63.65
Total Value
$5.04M
Shares Held After
117,066
% of Holdings
40.3%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
93,604
Price
$63.25
Total Value
$5.92M
Shares Held After
196,179
% of Holdings
32.3%
Inhibrx Biosciences, Inc. (INBX)
Kayyem Jon Faiz — Director
Shares
5,000
Price
$100.00
Total Value
$500.00K
Shares Held After
429,360
% of Holdings
1.2%
Upstream Bio, Inc. (UPB)
Deykin Aaron — Chief Medical Officer
Shares
895
Price
$5.49
Total Value
$4.91K
Shares Held After
32,302
% of Holdings
2.7%
Upstream Bio, Inc. (UPB)
Houghton Adam — Chief Business Officer
Shares
700
Price
$5.49
Total Value
$3.84K
Shares Held After
22,901
% of Holdings
3.0%
Upstream Bio, Inc. (UPB)
Sutherland Everett Rand — Director
Shares
2,095
Price
$5.49
Total Value
$11.50K
Shares Held After
68,717
% of Holdings
3.0%
Upstream Bio, Inc. (UPB)
GRAY MICHAEL — CFO and COO
Shares
853
Price
$5.49
Total Value
$4.68K
Shares Held After
27,942
% of Holdings
3.0%
Upstream Bio, Inc. (UPB)
Ambrose Allison — General Counsel
Shares
485
Price
$5.49
Total Value
$2.66K
Shares Held After
15,563
% of Holdings
3.0%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
11,000
Price
$0.21
Total Value
$2.31K
Shares Held After
102,822
% of Holdings
10.7%
Adagene Inc. (ADAG)
Luo Peter — Director
Shares
20,290
Price
$3.15
Total Value
$63.98K
Shares Held After
88,535
% of Holdings
22.9%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,340
Price
$1.29
Total Value
$10.75K
Shares Held After
892,101
% of Holdings
0.9%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
15,000
Price
$96.09
Total Value
$1.44M
Shares Held After
553,209
% of Holdings
2.6%
Showing 151–200 of 793 transactions (page 4 of 16)